lifestyle.realie.org

Author: Aspire Biopharma Holdings, Inc.

Aspire Biopharma’s Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion

April 15, 2026
Aspire Biopharma’s Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion

March 19, 2026
Aspire Biopharma’s Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

March 17, 2026
Aspire Biopharma’s Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026

March 12, 2026
Aspire Biopharma’s BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

March 10, 2026
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

March 3, 2026
Aspire Biopharma’s Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship

February 25, 2026
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements

February 20, 2026
Aspire Biopharma’s Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record

February 19, 2026
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

February 17, 2026